Indian Vaccine Maker Bharat Biotech Is Said to Mull $500 Million IPO
Indian vaccine developer Bharat Biotech International Ltd. is considering an initial public offering that may raise more than $500 million, according to people familiar with the matter.
By Dave Sebastian, Baiju Kalesh · Bloomberg Markets
Indian vaccine developer Bharat Biotech International Ltd. is considering an initial public offering that may raise more than $500 million, according to people familiar with the matter.